A total of 350, 997 hospital discharges due to CKD were recorded in Mexico during the period studied, with 2017 exhibiting the greatest number of discharges (n=120,746), compared to years 2016 (n=116, 218) and 2018 (n=114, 033); with 7646 aged <15 years.

Both, at the national level (71.84%; n=249,130) and in Yucatan (91.17%; n=3832), in most discharges, the stage of CKD was not specified or recorded in the adult population. Among the records of patients admitted with a first-time diagnosis, women experienced greater hospital mortality (8.38%; n=212) (p=<0.01).

In general, 28,783 deaths due to CKD took place in Mexico in the studied period (2135<15 years of age) mortality rate from this cause was 23 per 100,000 inhabitants at the national level and 25 per 100,000 in Yucatan. 82.77% (n=23, 349) of the national deaths and 86.50% (n=487) of those that occurred in Yucatan were not classified by stage of CKD. In Yucatan, there were a proportionally greater mortality among patients <15 years (Table 1).

In Mexico, 9316 kidney transplants were recorded, the modal year was 2017 during the study period, at a national level, but in Yucatan there was a decrease in transplants between 2016 and 2018. For receivers of age ≥15, the percentage of live donors was significantly greater. The transplant rate per 1,000,000 inhabitants was 74 at the national level and 41 in Yucatan. In the state of Yucatan, a progressive decrease in the proportion of cadaver donors per year (50%–23%), whilst the live donors were observed to be increasing (50%–77%) (Table 2). A total of 516,287 dialysis procedures were recorded during the period, of these, the Haemodialysis (HD) was the most common RRT (79.65%, n=411,222), whilst Peritoneal Dialysis (PD) was less common (20.35%, n=105,065), as shown in Table 2.

We have presented the epidemiological panorama of CKD in México, with emphasis on the state of Yucatán. The frequency of intrahospital infections was increased as the days of hospitalization also increased, which is consistent with what has been reported in other studies7,8; additionally, the hospital infection was most frequent among those that were discharged due to death.

Mexico ranks second place in Latin American countries in respect to the number of patients that are using PD modality. However, it has been reported that the access to RRT, is unequal in the population due to their affiliation with the health services, A large part of the population is affiliated with public services; however, medical coverage is limited in these patients, because CKD and RRT translates to a large economic burden for the patients and struggle to comply with the expenses for the adequate care necessary for disease management.9,10 Finally, it is important to mention that the current surveillance system of CKD in Mexico does not include patient-centred statistics, follow ups nor a record of patients that have PD at home. New efforts are needed to improve monitoring of patients since their diagnosis, this could orient on progression timing, survival and other indicators that could be sensible to change along with new health approaches and therapeutic innovations and permit contrasting the Mexican trends in CKD with those from around the world. Improving health care and timely diagnosis in Mexico, particularly in the states with higher prevalence of obesity, diabetes, and hypertension, such as Yucatan may be considered as essential for the well being and prognosis of patients.